PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 170 filers reported holding PTC THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,570,000 | -64.0% | 147,280 | -61.2% | 0.38% | -50.6% |
| Q4 2019 | $18,241,000 | +45.0% | 379,788 | +2.1% | 0.77% | +31.2% |
| Q3 2019 | $12,578,000 | -28.0% | 371,908 | -4.1% | 0.59% | -16.3% |
| Q2 2019 | $17,460,000 | +54.9% | 388,010 | +29.6% | 0.70% | +52.7% |
| Q1 2019 | $11,271,000 | +48.3% | 299,431 | +35.2% | 0.46% | +22.7% |
| Q4 2018 | $7,602,000 | -28.3% | 221,503 | -1.8% | 0.37% | -3.9% |
| Q3 2018 | $10,596,000 | +137.8% | 225,450 | +63.9% | 0.39% | +85.2% |
| Q4 2015 | $4,456,000 | +641.4% | 137,524 | +510.8% | 0.21% | +577.4% |
| Q3 2015 | $601,000 | – | 22,514 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |